Results
|
1221.
|
|
|
1222.
|
|
|
1223.
|
|
|
1224.
|
|
|
1225.
|
|
|
1226.
|
|
|
1227.
|
|
|
1228.
|
Retreatment with trastuzumab-based therapy after disease progression following lapatinib in HER2-positive metastatic breast cancer. [electronic resource] by
- Gori, S
- Montemurro, F
- Spazzapan, S
- Metro, G
- Foglietta, J
- Bisagni, G
- Ferzi, A
- Silva, R R
- Gamucci, T
- Clavarezza, M
- Stocchi, L
- Fabi, A
- Cognetti, F
- Torrisi, E
- Crivellari, D
Producer: 20120920
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 23
Availability: No items available.
|
|
1229.
|
Role of HER2-Related Biomarkers (HER2, p95HER2, HER3, PTEN, and PIK3CA) in the Efficacy of Lapatinib plus Capecitabine in HER2-Positive Advanced Breast Cancer Refractory to Trastuzumab. [electronic resource] by
- Nishimura, Reiki
- Toh, Uhi
- Tanaka, Maki
- Saimura, Michiyo
- Okumura, Yasuhiro
- Saito, Tsuyoshi
- Tanaka, Toshihiro
- Teraoka, Megumi
- Shimada, Kazuo
- Katayama, Kazuhisa
- Koga, Toshihiro
- Kurashita, Kaname
- Hasegawa, Satoshi
- Todoroki, Hidekazu
- Kai, Yuichiro
- Ohi, Yasuyo
- Toyoshima, Satoshi
- Arima, Nobuyuki
- Mitsuyama, Shoshu
- Tamura, Kazuo
Producer: 20171018
In:
Oncology vol. 93
Availability: No items available.
|
|
1230.
|
Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial. [electronic resource] by
- Shi, W
- Jiang, T
- Nuciforo, P
- Hatzis, C
- Holmes, E
- Harbeck, N
- Sotiriou, C
- Peña, L
- Loi, S
- Rosa, D D
- Chia, S
- Wardley, A
- Ueno, T
- Rossari, J
- Eidtmann, H
- Armour, A
- Piccart-Gebhart, M
- Rimm, D L
- Baselga, J
- Pusztai, L
Producer: 20180501
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 28
Availability: No items available.
|
|
1231.
|
Does dual HER-2 blockade treatment increase the risk of severe toxicities of special interests in breast cancer patients: A meta-analysis of randomized controlled trials. [electronic resource] by
- Hao, Shuai
- Tian, Wuguo
- Gao, Bo
- Jiang, Yan
- Zhang, Xiaohua
- Zhang, Shu
- Guo, Lingji
- Zhao, Jianjie
- Zhang, Gang
- Hu, Chunyan
- Yan, Jie
- Luo, Donglin
Producer: 20170831
In:
Oncotarget vol. 8
Availability: No items available.
|
|
1232.
|
|
|
1233.
|
|
|
1234.
|
|
|
1235.
|
A multidisciplinary approach to the management of breast cancer, part 2: therapeutic considerations. [electronic resource] by
- Pruthi, Sandhya
- Boughey, Judy C
- Brandt, Kathleen R
- Degnim, Amy C
- Dy, Grace K
- Goetz, Matthew P
- Perez, Edith A
- Reynolds, Carol A
- Schomberg, Paula J
- Ingle, James N
Producer: 20071012
In:
Mayo Clinic proceedings vol. 82
Availability: No items available.
|
|
1236.
|
|
|
1237.
|
|
|
1238.
|
|
|
1239.
|
Randomized study of Lapatinib alone or in combination with trastuzumab in women with ErbB2-positive, trastuzumab-refractory metastatic breast cancer. [electronic resource] by
- Blackwell, Kimberly L
- Burstein, Harold J
- Storniolo, Anna Maria
- Rugo, Hope
- Sledge, George
- Koehler, Maria
- Ellis, Catherine
- Casey, Michelle
- Vukelja, Svetislava
- Bischoff, Joachim
- Baselga, Jose
- O'Shaughnessy, Joyce
Producer: 20100325
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 28
Availability: No items available.
|
|
1240.
|
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial. [electronic resource] by
- Baselga, José
- Bradbury, Ian
- Eidtmann, Holger
- Di Cosimo, Serena
- de Azambuja, Evandro
- Aura, Claudia
- Gómez, Henry
- Dinh, Phuong
- Fauria, Karine
- Van Dooren, Veerle
- Aktan, Gursel
- Goldhirsch, Aron
- Chang, Tsai-Wang
- Horváth, Zsolt
- Coccia-Portugal, Maria
- Domont, Julien
- Tseng, Ling-Min
- Kunz, Georg
- Sohn, Joo Hyuk
- Semiglazov, Vladimir
- Lerzo, Guillermo
- Palacova, Marketa
- Probachai, Volodymyr
- Pusztai, Lajos
- Untch, Michael
- Gelber, Richard D
- Piccart-Gebhart, Martine
Producer: 20120305
In:
Lancet (London, England) vol. 379
Availability: No items available.
|